FDA said it never inspected dental lab that made controversial AGGA device

A gene ther­a­py pi­o­neer thinks he has a so­lu­tion to the field’s strug­gle to com­mer­cial­ize break­through cures: Go glob­al. Jim Wil­son’s Philadel­phia-based com­pa­ny Gem­ma­Bio on

Adding financial incentives to meal replacement therapy for teens with severe obesity helped improve weight and body fat, although not cardiometabolic risk factors, a randomized